Related Documents
-
Notice: Food for human consumption: Hospira, Inc., et al.; approval withdrawn
811 reads -
Notice: Biological products:
Patent extension; regulatory review period determinations— Protamine sulfate injection, etc.
73 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— DURICEF (cefadroxil USP) tablets, 1 gram, and capsules, 500 milligrams
85 reads -
Notice: Human drugs:
New drug applications— Able Laboratories, Inc.; approval withdrawn
56 reads -
Notice: Human drugs:
New drug applications— Able Laboratories, Inc.; approval withdrawn
79 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
28 reads -
belajarmembuatwebsite
505 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— REVLIMID
42 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— LAMICTAL (lamotrigene) Tablets, 50 and 250 milligrams
66 reads -
Arti Huruf Depan Anda
1143 reads -
Notice: Meetings:
21 reads -
Notice: Meetings: Health Care Policy and Research Special Emphasis Panel
12 reads -
Notice: Human drugs:
New drug applications— King Pharmaceuticals, Inc., et al.; approval withdrawn
68 reads -
Notice: Human drugs:
New drug applications— INSPRA
191 reads -
Am Ox It Id
1772 reads -
How to Install Windows XP
1171 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Prevacid naprapac
45 reads -
Notice: Committees; establishment, renewal, termination, etc.: Medical Devices Advisory Committee
33 reads -
Norainil Hawa Apakah Itu Blog
169 reads
Related Documents
Flag this document
6 Pages
